Mortality Risk and Pulmonary Function in Adults With Cystic Fibrosis at Time of Wait Listing for Lung Transplantation Don Hayes, MD, MS, Stephen Kirkby,

Slides:

Advertisements

Similar presentations

Changes in Risk Profile Over Time in the Population of a Pediatric Heart Transplant Program Olaf Reinhartz, MD, Katsuhide Maeda, MD, Bruce A. Reitz, MD,

Advertisements

Survival After Single Versus Bilateral Lung Transplantation for High-Risk Patients With Pulmonary Fibrosis Eric S. Weiss, MD, MPH, Jeremiah G. Allen,

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Roland Assi, MD, MMS, Daniel J. Wong, MD, Daniel J. Boffa, MD, Frank C

Reply The Annals of Thoracic Surgery

The Society of Thoracic Surgeons Lung Cancer Resection Risk Model: Higher Quality Data and Superior Outcomes Felix G. Fernandez, MD, MS, Andrzej S. Kosinski,

Postoperative Atrial Fibrillation Prophylaxis After Lung Surgery: Systematic Review and Meta-Analysis Lars Peter Riber, MD, PhD, Torben Bjerregaard Larsen,

Zhiqiang Xue, MD, Fengying Wu, MD, Karlyn E

Trevor Williams, MD, MPH, Brian C

Thoracic Epidural Versus Intercostal Nerve Catheter Plus Patient-Controlled Analgesia: A Randomized Study James D. Luketich, MD, Stephanie R. Land, PhD,

David P. Mason, MD, Jeevanantham Rajeswaran, MS, Sudish C

Harm H. H. Feringa, MD, Leslee J

Todd C. Crawford, MD, J. Trent Magruder, MD, Joshua C

Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation Don Hayes, MD, MS, Sylvester M. Black,

B. Zane Atkins, MD, Rebecca P. Petersen, MD, MS, Mani A

Using Surgeon-Specific Outcome Reports and Positive Deviance for Continuous Quality Improvement Jelena Ivanovic, MS, PhD, Caitlin Anstee, BA, Tim Ramsay,

Robert E. Freundlich, MD, MS, Michael D. Maile, MD, MS, Mark M

Castigliano M. Bhamidipati, DO, MS, George J

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Punkaj Gupta, MBBS, Brandon W. Beam, JD, Tommy R

Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin

Linda Henry, PhD, RN, Linda Halpin, MSN, RN, Sharon Hunt, MBA, Sari D

Readmission to Intensive Care Unit After Initial Recovery From Major Thoracic Oncology Surgery Suk-Won Song, MD, Hyun-Sung Lee, MD, PhD, Jae-Hyun Kim,

Therapeutic Bronchoscopy Interventions Before Surgical Resection of Lung Cancer Prashant N. Chhajed, MD, Ralf Eberhardt, MD, Hendrik Dienemann, MD, Andrea.

Trevor Williams, MD, MPH, Brian C

Analyzing Effectiveness of Routine Pleural Drainage After Nuss Procedure: A Randomized Study Krystian Pawlak, MD, PhD, Łukasz Gąsiorowski, MD, PhD, Piotr.

Who Do You Say You Are? The Annals of Thoracic Surgery

Right Ventricular Systolic Dysfunction Assessed by Cardiac Magnetic Resonance Is a Strong Predictor of Cardiovascular Death After Coronary Bypass Grafting

Tara R. Semenkovich, MD, MPHS, Christine Frederiksen, MS, Jessica L

Saving Lives Is More Important Than Abstract Moral Concerns: Financial Incentives Should Be Used to Increase Organ Donation Benjamin Hippen, MD, Lainie.

Management of Intersegmental Plane on Pulmonary Segmentectomy Concerning Postoperative Complications Hajime Saito, MD, PhD, Hayato Konno, MD, PhD, Maiko.

Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis Shahid I. Sheikh, MD, Don Hayes,

Use of Amiodarone After Major Lung Resection

Transcatheter Aortic Valve Replacement Outcomes in Nonagenarians Stratified by Transfemoral and Transapical Approach Christian McNeely, MD, Alan Zajarias,

Effects of Blood Transfusion on Cause-Specific Late Mortality After Coronary Artery Bypass Grafting—Less Is More Thomas A. Schwann, MD, Joseph R. Habib,

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U.

Alex K. Bryant, BS, Robert C. Mundt, HSDG, Ajay P. Sandhu, MD, James J

Mallory L. Irons, MD, MBE, J. William Gaynor, MD, Thomas L

Andrew P. Dhanasopon, MD, Michelle C. Salazar, MD, Jessica R

Risk Factors for Atrial Fibrillation After Lung Cancer Surgery: Analysis of The Society of Thoracic Surgeons General Thoracic Surgery Database Mark Onaitis,

Lung Function and ECMO After Lung Transplantation

Outcomes of Delayed Chest Closure After Bilateral Lung Transplantation

Coronary Artery Bypass Revascularization Using Bilateral Internal Thoracic Arteries in Diabetic Patients: A Systematic Review and Meta-Analysis Kan Kajimoto,

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.

Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Mark F. Berry, MD, Chi-Fu Jeffrey.

The Association of Chronic Lung Disease With Early Mortality and Respiratory Adverse Events After Aortic Valve Replacement Juan A. Crestanello, MD, Robert.

Characteristics of Malignant Pleural Mesothelioma in Women

Editorial Board, January 2010

Office-Based Spirometry: A New Model of Care in Preoperative Assessment for Low- Risk Lung Resections Jessica L. Hudson, MD, MPHS, Jennifer M. Bell, BSN,

Sarah C. Huen, MD, Chirag R. Parikh, MD, PhD

Understanding Mortality as a Quality Indicator After Esophagectomy

Michael T. Durheim, MD, Sunghee Kim, PhD, Brian C

Limitations of Hospital Volume as a Measure of Quality of Care for Coronary Artery Bypass Graft Surgery Karl F. Welke, MD, Mitchell J. Barnett, PharmD,

Anirudh Vinnakota, MS, Robert Stewart, MD, Gosta Pettersson, MD, PhD

What Is the Role of Minimally Invasive Mitral Valve Surgery in High-Risk Patients? A Meta-Analysis of Observational Studies Marco Moscarelli, MD, Khalil.

Predicted Versus Observed FEV1 and Dlco After Major Lung Resection: A Prospective Evaluation at Different Postoperative Periods Alessandro Brunelli,

David P. Mason, MD, Chase R. Brown, BS, Sudish C

Sebastien Gilbert, MD, Sonam Maghera, BS, Andrew J

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Scott B. Johnson, MD, Anna M. Allred, BS, Adam M. Cline, MD, Luis F

Defining Patient-Prosthesis Mismatch and Its Effect on Survival in Patients With Impaired Ejection Fraction David A. Cotoni, DO, Robert T. Palac, MD,

Dana Y. Fuhrman, DO, MS, Lan G

Sequential Bilateral Bronchoscopic Lung Volume Reduction With One-Way Valves for Heterogeneous Emphysema Alfonso Fiorelli, MD, PhD, Antonio D’Andrilli,

Creation of a Quantitative Score to Predict the Need for Mechanical Support in Children Awaiting Heart Transplant Ryan R. Davies, MD, Shylah Haldeman,

Sagar U. Nigwekar, MD, Praveen Kandula, MD, MPH

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Benjamin D. Kozower, MD, MPH, Shubin Sheng, PhD, Sean M

Presentation transcript:

Mortality Risk and Pulmonary Function in Adults With Cystic Fibrosis at Time of Wait Listing for Lung Transplantation Don Hayes, MD, MS, Stephen Kirkby, MD, Bryan A. Whitson, MD, PhD, Sylvester M. Black, MD, PhD, Shahid I. Sheikh, MD, Joseph D. Tobias, MD, Heidi M. Mansour, PhD, Benjamin T. Kopp, MD The Annals of Thoracic Surgery Volume 100, Issue 2, Pages 474-479 (August 2015) DOI: 10.1016/j.athoracsur.2015.04.022 Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Predicted hazard ratio (HR) of lung transplantation (LTx) among patients with cystic fibrosis by forced expiratory volume in 1 second (FEV1) at wait list (WL) entry. Deaths are assessed on list and after lung transplant. (CI = confidence interval.) The Annals of Thoracic Surgery 2015 100, 474-479DOI: (10.1016/j.athoracsur.2015.04.022) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Predicted hazard ratio (HR) of lung transplantation (LTx) among patients with cystic fibrosis by forced vital capacity (FVC) at wait list (WL) entry. Deaths are assessed on list and after lung transplant. (CI = confidence interval.) The Annals of Thoracic Surgery 2015 100, 474-479DOI: (10.1016/j.athoracsur.2015.04.022) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions